Colgate-Palmolive insider plans $920K stock sale

COLGATE PALMOLIVE CO (CL) insider Panagiotis Tsourapas filed a notice of proposed sale of 10,000 shares of common stock of Colgate-Palmolive.

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO (CL) insider Panagiotis Tsourapas filed a notice of proposed sale of 10,000 shares of common stock of Colgate-Palmolive. The shares are to be sold through Merrill Lynch on the NYSE, with an aggregate market value listed as $920,477.17.

The filing also lists equity awards that will provide shares in the future, including 799 shares from vesting of restricted stock unit awards on 09/13/2024 and 9,201 shares from vesting of performance share unit awards on 02/23/2026, all granted under Colgate-Palmolive’s equity compensation plan.

Key Figures

Common stock shares to be sold: 10,000 shares Aggregate market value: $920,477.17 CUSIP: 797172829 +4 more

7 metrics

Common stock shares to be sold 10,000 shares Shares of Colgate-Palmolive common stock covered by the Form 144 notice

Aggregate market value $920,477.17 Aggregate market value for 10,000 Colgate-Palmolive shares in the Form 144

CUSIP 797172829 CUSIP number associated with Colgate-Palmolive common stock in the filing

RSU vesting shares 799 shares Shares from vesting of restricted stock unit awards on 09/13/2024

PSU vesting shares 9,201 shares Shares from vesting of performance share unit awards on 02/23/2026

RSU vesting date 09/13/2024 Vesting date for 799 restricted stock unit award shares

PSU vesting date 02/23/2026 Vesting date for 9,201 performance share unit award shares

Key Terms

Rule 144, restricted stock unit awards, performance share unit awards, equity compensation plan

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock unit awards financial

"Vesting of restricted stock unit awards | COLGATE PALMOLIVE CO"

Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.

performance share unit awards financial

"Vesting of performance share unit awards | COLGATE PALMOLIVE CO"

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Colgate-Palmolive (CL) insider Panagiotis Tsourapas plan to sell under this Form 144?

The notice covers a proposed sale of 10,000 shares of Colgate-Palmolive common stock, to be sold through Merrill Lynch on the NYSE, with an aggregate market value shown as $920,477.17 at the time of the filing.

Which equity awards for Colgate-Palmolive (CL) are referenced in this Form 144?

The filing lists restricted stock unit awards and performance share unit awards granted under Colgate-Palmolive’s equity compensation plan, with 799 shares vesting on 09/13/2024 and 9,201 shares vesting on 02/23/2026.

What is the aggregate market value of the Colgate-Palmolive (CL) shares covered by this Form 144?

The Form 144 states that the 10,000 shares of Colgate-Palmolive common stock proposed to be sold have an aggregate market value of $920,477.17 based on the information provided in the filing.

On which exchange are the Colgate-Palmolive (CL) shares in this Form 144 expected to be sold?

The Form 144 notes that the 10,000 shares of Colgate-Palmolive common stock are to be sold on the NYSE, with Merrill Lynch listed as the broker for the transaction.

Who is the reporting person in this Colgate-Palmolive (CL) Form 144 filing?

The Form 144 identifies Panagiotis Tsourapas as the person for whose account the Colgate-Palmolive common stock is to be sold, and indicates that this person is an officer of the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:50 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:49 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001576945
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COLGATE PALMOLIVE CO
SEC File Number	001-00644
Address of Issuer	300 PARK AVE NEW YORK NEW YORK 10022
Phone	2123102000
Name of Person for Whose Account the Securities are To Be Sold	Tsourapas Panagiotis
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	10000	920477.17	797172829	08/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/13/2024	Vesting of restricted stock unit awards	COLGATE PALMOLIVE CO			799	09/13/2024	Granted as part of issuer equity compensation plan
Common Stock	02/23/2026	Vesting of performance share unit awards	COLGATE PALMOLIVE CO			9201	02/23/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Tsourapas Panagiotis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)